Stocksigma LogoStocksigma Logo

Chandra Bhagat Pharma Approves Allotment of 66 Lakh Preferential Convertible Warrants

Chandra Bhagat Pharma Limited's Board has approved the preferential allotment of 66,00,000 convertible warrants at an issue price of Rs

Chandra Bhagat Pharma Approves Allotment of 66 Lakh Preferential Convertible Warrants

Chandra Bhagat Pharma Ltd 路 Others (Uncategorized) 路 22 Oct 2026, 5:59 pm

Chandra Bhagat Pharma Approves Allotment of 66 Lakh Preferential Convertible Warrants Chandra Bhagat Pharma Limited's Board has approved the preferential allotment of 66,00,000 convertible warrants at an issue price of Rs. 44 each (face value Rs. 10) to nine promoter and non-promoter investors. The company received an upfront consideration of Rs. 7.26 cr. Each warrant is convertible into one equity share (1:1 ratio) within 18 months from allotment upon receipt of the remaining consideration. Post-conversion, promoters and promoter group entities will hold the majority, while non-promoters Samir Dave and Chintan Makhecha will each hold 5.66%.

Original exchange filing (PDF)

More announcements from Chandra Bhagat Pharma Ltd

All Chandra Bhagat Pharma Ltd announcements